Clinical Trials · NCT06976853
Moving Beyond Inflammation as a Therapeutic Target for Crohn's Disease
- Phase
- Phase 2
- Recruitment status
- Recruiting
- Sponsor
- Washington University School of Medicine
- Enrollment
- 60
- Start date
- May 2025
- Locations
- 3 sites, United States
- Primary endpoint
- Proportion and number of participants who have treatment emergent adverse events, serious adverse events, discontinuation of study intervention due to adverse events and injection-site reactions by CTCAE v4.0